z-logo
open-access-imgOpen Access
Spinal Cord Stimulation for Treating Chronic Pain: Reviewing Preclinical and Clinical Data on Paresthesia‐Free High‐Frequency Therapy
Author(s) -
Chakravarthy Krishnan,
Richter Hira,
Christo Paul J.,
Williams Kayode,
Guan Yun
Publication year - 2018
Publication title -
neuromodulation: technology at the neural interface
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.296
H-Index - 60
eISSN - 1525-1403
pISSN - 1094-7159
DOI - 10.1111/ner.12721
Subject(s) - medicine , chronic pain , clinical trial , spinal cord stimulation , spinal cord stimulator , preclinical research , physical medicine and rehabilitation , physical therapy , stimulation , medical physics , pathology
Background Traditional spinal cord stimulation (SCS) requires that paresthesia overlaps chronic painful areas. However, the new paradigm high‐frequency SCS (HF‐SCS) does not rely on paresthesia. Study Design A review of preclinical and clinical studies regarding the use of paresthesia‐free HF‐SCS for various chronic pain states. Methods We reviewed available literatures on HF‐SCS, including Nevro's paresthesia‐free ultra high‐frequency 10 kHz therapy (HF10‐SCS). Data sources included relevant literature identified through searches of PubMed, MEDLINE/OVID, and SCOPUS, and manual searches of the bibliographies of known primary and review articles. Outcome Measures The primary goal is to describe the present developing conceptions of preclinical mechanisms of HF‐SCS and to review clinical efficacy on paresthesia‐free HF10‐SCS for various chronic pain states. Results HF10‐SCS offers a novel pain reduction tool without paresthesia for failed back surgery syndrome and chronic axial back pain. Preclinical findings indicate that potential mechanisms of action for paresthesia‐free HF‐SCS differ from those of traditional SCS. Conclusions To fully understand and utilize paresthesia‐free HF‐SCS, mechanistic study and translational research will be very important, with increasing collaboration between basic science and clinical communities to design better trials and optimize the therapy based on mechanistic findings from effective preclinical models and approaches. Future research in these vital areas may include preclinical and clinical components conducted in parallel to optimize the potential of this technology.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here